If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,170.00    30.00 (0.58%)
Bid:
5,160.00
Ask:
5,165.00
Spread: 5.00 (0.097%)
Market Cap: £18.84b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

23 Dec 2025 14:45

RNS Number : 7108M
Coca-Cola HBC AG
23 December 2025
 

FOR IMMEDIATE RELEASE

23 December 2025

 

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company notifies that the following PDMR has been granted at nil cost performance shares of CHF 6.70 each ("Shares") in the Company on 10 November 2025 through her participation in the Stock Option and Performance Share Award Plan ("PSP"). The performance shares will vest as described below subject to achievement of performance conditions.

 PDMR

Number of Shares granted under the PSP

Share price

PANAGIOTA KALOGERAKI

5,898.31

GBP 35.90

 

The Notification of Dealing Forms for each PDMR can be found below.

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

PANAGIOTA KALOGERAKI

2

 

Reason for the notification

a)

 

Position/status

 

CHIEF OPERATING OFFICER

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

COCA-COLA HBC AG

b)

 

LEI

 

549300EFP3TNG7JGVE49

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

SHARES

 

 

CH0198251305

b)

 

Nature of the transaction

 

 

GRANTING OF PERFORMANCE SHARES AT NIL COST WHICH WILL VEST IN NOVEMBER 2028 SUBJECT TO ACHIEVEMENT OF PERFORMANCE CONDITIONS OF THE 2025-2027 PERFORMANCE SHARE PLAN.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

35.90 GBP

5,898.31

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Price

Volume

Total

35.90 GBP

5,898.31

211,749.329 GBP

e)

 

Date of the transaction

 

2025-11-10

f)

 

Place of the transaction

 

OUTSIDE A TRADING VENUE

 

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation. The grant of the Shares was deferred for administrative reasons and to ensure compliance with the Market Abuse Regulation while the recipient was in possession of inside information.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHPKNBDQBDDCBB
Date   Source Headline
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.